• Who we are
  • Key topics
  • Publications
    • Factsheets
    • Infographics
    • Reports
    • Policy
    • Videos
    • Podcast – Conversations on EU Pharma
  • Newsroom
    • Press releases
    • In the news
    • Press kit
  • JOB OPPORTUNITIES
  • Contact us
Login Login
Medicines for Europe
  • Generic medicines
    • Home
    • Medicines for Europe
      • Generic medicines Group
      • MISSION AND VISION
      • STRUCTURE
      • MEMBERS
      • BECOME A MEMBER
    • Did you know?
      • Definition
      • THERAPEUTIC AREAS
      • GLOSSARY
      • Q&A
    • What’s new
      • FACTSHEETS
      • POLICY
      • REPORTS
      • VIDEOS
      • INFOGRAPHICS
    • Our 5 pillars
      • Patients
      • QUALITY
      • VALUE
      • SUSTAINABILITY
      • PARTNERSHIP
    • Find out more
      • Related links
      • Contact us
    • Twitter
  • Biosimilar medicines
    • Home
    • Medicines for Europe
      • Biosimilar medicines Group
      • MISSION AND VISION
      • STRUCTURE
      • MEMBERS
      • BECOME A MEMBER
    • Did you know?
      • DEFINITION
      • THERAPEUTIC AREAS
      • GLOSSARY
      • Q&A
    • What’s new
      • FACTSHEETS
      • POLICY
      • REPORTS
      • VIDEOS
      • INFOGRAPHICS
      • External resources
    • Our 5 pillars
      • Patients
      • QUALITY
      • VALUE
      • SUSTAINABILITY
      • PARTNERSHIP
    • Find out more
      • Related links
      • Contact us
    • Twitter
  • Value added medicines
    • Home
    • Who we are
      • Value added medicines Group
      • MISSION AND VISION
      • STRUCTURE
      • MEMBERS
      • BECOME A MEMBER
    • Did you know?
      • Environment of value added medicines in Europe
      • Definition
      • THERAPEUTIC AREAS
      • Q&A
    • What’s new
      • Environment of value added medicines in Europe
      • FACTSHEETS
      • POLICY
      • REPORTS
      • VIDEOS
      • INFOGRAPHICS
      • Value Added Medicines award 2019
      • QUOTES
    • Our 5 pillars
      • Patients
      • QUALITY
      • VALUE
      • SUSTAINABILITY
      • PARTNERSHIP
    • Find out more
      • Contact us
  • Events

IGBA 2017 achievements – Adrian van den Hoven

21 December 2017

Related Posts

  • Christoph Stoller and Adrian van den Hoven interviewed by… 17 July 2020 In the wake of the publication of Medicines for Europe’s Lessons…
  • Margaritis Schinas and Adrian Van Den Hoven visited ELPEN 15 November 2021 The Vice President of the European Commission for promoting our…
  • Resolving and mitigating medicine shortages in the EU 10 February 2020 Drug shortages can greatly impact patients and the pharmaceutical industry.…
  • Interview: Medicines for Europe Reports on EU Biosimilar… 27 July 2020 The Center for Biosimilars® (CfB) spoke with Adrian van den Hoven,…
Medicines for Europe
MEMBER OF
IGBA EMVO
  • Contact us
  • Privacy Policy
Medicines for Europe AISBL
Rue d’Arlon 50
1000 Brussels Belgium
T : +32 (0)2 736 84 11
Powered by Big Smile Agency
Medicines For Europe
  • Who we are
    • WHO WE ARE – ABOUT MEDICINES FOR EUROPE
    • Purpose and Objectives
    • OUR VALUES
    • STRUCTURE
    • OUR MEMBERS
    • BECOME A MEMBER
    • CODE OF CONDUCT
    • DISCLOSURE
    • JOB OPPORTUNITIES
  • Key topics
    • COVID-19
    • Access
    • INDUSTRIAL POLICY
    • REGULATORY AND LEGAL FRAMEWORK
    • FALSIFIED MEDICINES
    • ENVIRONMENT
    • ANTIMICROBIAL RESISTANCE
    • MEDICINE SHORTAGES
  • Publications
    • Factsheets
    • Infographics
    • Reports
    • Policy
    • Videos
    • Podcast – Conversations on EU Pharma
  • Newsroom
    • Press releases
    • In the news
    • Press kit
  • Contact us
  • SECTOR GROUPS
    • Generic medicines
      • WHO WE ARE
      • DID YOU KNOW?
      • WHAT’S NEW
      • OUR 5 PILLARS
      • FIND OUT MORE
    • Biosimilar medicines
      • WHO WE ARE
      • DID YOU KNOW?
      • WHAT’S NEW
      • OUR 5 PILLARS
      • FIND OUT MORE
    • Value added medicines
      • WHO WE ARE
      • DID YOU KNOW?
      • WHAT’S NEW
      • OUR 5 PILLARS
  • Events
 Tweet
 Tweet
 Tweet
 LinkedIn